ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer

Xi, Gangqin; Qiu, Lida; Xu, Shuoyu; Guo, Wenhui; Fu, Fangmeng; Kang, Deyong; Zheng, Liqin; He, Jiajia; Zhang, Qingyuan; Li, Lianhuang*; Wang, Chuan*; Chen, Jianxin*南方医科大学; 哈尔滨医科大学
BMC Medicine2021-11-18DOI: 10.1186/s12916-021-02146-7
19被引6阅读
引用收藏
分享

摘要

Background Collagen fibers play an important role in tumor initiation, progression, and invasion. Our previous research has already shown that large-scale tumor-associated collagen signatures (TACS) are powerful prognostic biomarkers independent of clinicopathological factors in invasive breast cancer. However, they are observed on a macroscale and are more suitable for identifying high-risk patients. It is necessary to investigate the effect of the corresponding microscopic features of TACS so as to more accurately and comprehensively predict the prognosis of breast cancer patients. Methods In this retrospective and multicenter study, we included 942 invasive breast cancer patients in both a training cohort (n = 355) and an internal validation cohort (n = 334) from one clinical center and in an external validation cohort (n = 253) from a different clinical center. TACS corresponding microscopic features (TCMFs) were firstly extracted from multiphoton images for each patient, and then least absolute shrinkage and selection operator (LASSO) regression was applied to select the most robust features to build a TCMF-score. Finally, the Cox proportional hazard regression analysis was used to evaluate the association of TCMF-score with disease-free survival (DFS). Results TCMF-score is significantly associated with DFS in univariate Cox proportional hazard regression analysis. After adjusting for clinical variables by multivariate Cox regression analysis, the TCMF-score remains an independent prognostic indicator. Remarkably, the TCMF model performs better than the clinical (CLI) model in the three cohorts and is particularly outstanding in the ER-positive and lower-risk subgroups. By contrast, the TACS model is more suitable for the ER-negative and higher-risk subgroups. When the TACS and TCMF are combined, they could complement each other and perform well in all patients. As expected, the full model (CLI+TCMF+TACS) achieves the best performance (AUC 0.905, [0.873-0.938]; 0.896, [0.860-0.931]; 0.882, [0.840-0.925] in the three cohorts). Conclusion These results demonstrate that the TCMF-score is an independent prognostic factor for breast cancer, and the increased prognostic performance (TCMF+TACS-score) may help us develop more appropriate treatment protocols.

学科与关键词

关键词
Breast cancerMultiphoton imagingTACS corresponding microscopic featuresPrognosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMC Medicine
发表日期
2021-11-18
卷期
第 19 卷, 第 1 期
页码
273
DOI
10.1186/s12916-021-02146-7
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82171991, 81700576]; Fujian Major Scientific and Technological Special Project for "Social Development" [2020YZ016002]; Natural Science Foundation of Fujian Province [2019J01269, 2020J011008, 2020J01839]; Joint Funds for the Innovation of Science and Technology of Fujian Province [2017Y9038, 2019Y9101]; special Funds of the Central Government Guiding Local Science and Technology Development [2020L3008]

作者

  • X

    Xi, Gangqin (第一作者)

    fujian normal univ

  • Q

    Qiu, Lida

    minjiang univ · fujian normal univ

查看全部 12 位作者收起作者
  • X

    Xu, Shuoyu

    southern med univ

  • G

    Guo, Wenhui

    fujian med univ

  • F

    Fu, Fangmeng

    fujian med univ

  • K

    Kang, Deyong

    fujian med univ

  • Z

    Zheng, Liqin

    fujian normal univ

  • H

    He, Jiajia

    fujian normal univ

  • Z

    Zhang, Qingyuan

    harbin med univ

  • L

    Li, Lianhuang (通讯)

    fujian normal univ

  • W

    Wang, Chuan (通讯)

    fujian med univ

  • C

    Chen, Jianxin (通讯)

    fujian normal univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417